SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001787
Filing Date
2021-09-13
Accepted
2021-09-13 16:16:28
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icvx-20210630.htm   iXBRL 10-Q 2761116
2 EX-31.1 icvx-20210630ex31_1.htm EX-31.1 18804
3 EX-31.2 icvx-20210630ex31_2.htm EX-31.2 17502
4 EX-32.1 icvx-20210630ex32_1.htm EX-32.1 10186
5 EX-32.2 icvx-20210630ex32_2.htm EX-32.2 10409
  Complete submission text file 0000950170-21-001787.txt   8420548

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT icvx-20210630_def.xml EX-101.DEF 207288
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT icvx-20210630_cal.xml EX-101.CAL 27083
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT icvx-20210630_pre.xml EX-101.PRE 318561
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT icvx-20210630_lab.xml EX-101.LAB 401294
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT icvx-20210630.xsd EX-101.SCH 48154
11 EXTRACTED XBRL INSTANCE DOCUMENT icvx-20210630_htm.xml XML 1392221
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40655 | Film No.: 211249867
SIC: 2836 Biological Products, (No Diagnostic Substances)